Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1 fusion-positive non-small cell lung cancer (TRIDENT-1 study) Meeting Abstract
| Authors: | Cho, B. C.; Drilon, A. E.; Doebele, R. C.; Kim, D. W.; Lin, J. J.; Lee, J.; Ahn, M. J.; Zhu, V. W.; Ejadi, S.; Camidge, D. R.; Liu, Y. J.; Stopatschinskaja, S.; Cui, J. J.; Hyman, D. M.; Ou, S. H. I.; Shaw, A. T. |
| Abstract Title: | Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1 fusion-positive non-small cell lung cancer (TRIDENT-1 study) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 479s |
| Language: | English |
| ACCESSION: | WOS:000487345806456 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.9011 |
| Notes: | Meeting Abstract: 9011 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work